Cargando…
Is It Time to Revisit Remdesivir Use for Severe COVID-19?
How to cite this article: Taggarsi DA. Is It Time to Revisit Remdesivir Use for Severe COVID-19? Indian J Crit Care Med 2022;26(9):983–984.
Autor principal: | Taggarsi, Dipali Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492745/ https://www.ncbi.nlm.nih.gov/pubmed/36213702 http://dx.doi.org/10.5005/jp-journals-10071-24317 |
Ejemplares similares
-
Placenta in the Critically Ill Mother
por: Taggarsi, Dipali Anand, et al.
Publicado: (2021) -
Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021) -
Compassionate Use of Remdesivir for Patients with Severe Covid-19
por: Grein, Jonathan, et al.
Publicado: (2020) -
A Rare Case of Spontaneous Anterior Abdominal Wall Necrotizing Soft Tissue Infection Caused by Finegoldia magna
por: Thomas, Nimisha, et al.
Publicado: (2021) -
The Goldilocks Time for Remdesivir — Is Any Indication Just Right?
por: Heil, Emily L., et al.
Publicado: (2021)